Abstract
Objectives To observe outbreak of COVID-19 in Henan province caused by the output population from Wuhan, and high-grade control measures were proformed in Henan province, to study the phase of development and change of the epidemic in Henan province, and to make appropriate inferences about the influence of prevention and control measures and the phase of development of the epidemic.
Methods Linear regression analysis were used to establish a linear regression model with the number of Wuhan roaming people as the dependent variable and the cumulative number of COVID-19 cases in Henan province as the dependent variable, and to calculate and plot the regional distribution of the number of cases in 18 cities in Henan province in accordance with the criteria of whether the number of cases exceeded the expected number.
Results There was a linear correlation between the number of people Wuhan roaming and the number of cases, and the linear regression model equation was statistically significant. The cities that exceeded the expected number of cases had a clear spatio-temporal distribution. Geographically, these cities were roughly in the 1 o’clock and 2 o’clock directions in Nanyang, and in terms of time period, the first phase (10 days), the cities that exceeded the expected number of cases changed almost daily. In the second phase (5 days), cities that exceeded the expected number of cases were moderated, and in the third phase (15 days), cities that exceeded the expected number of cases entered the stabilization phase.
Conclusions The priority cities for COVID-19 prevention and control in Henan province should pay special attention to the cities that have exceeded the expected number of COVID-19 cases, and the implementation of high-level control measures can effectively control the spread of COVID-19 within 2-4 weeks during the early stage of the epidemic.
Competing Interest Statement
The authors have declared no competing interest.
Funding Statement
There is no external funding, and there is no conflict of interests.
Author Declarations
All relevant ethical guidelines have been followed; any necessary IRB and/or ethics committee approvals have been obtained and details of the IRB/oversight body are included in the manuscript.
Yes
All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.
Yes
Data Availability
All data, models, and code generated or used during the study appear in the submitted article.
